Systems Modeling of Anti-apoptotic Pathways in Prostate Cancer: Psychological Stress Triggers a Synergism Pattern Switch in Drug Combination Therapy
暂无分享,去创建一个
Xiaobo Zhou | Jiguang Bao | Xiaoqiang Sun | King C. Li | Kyle C. Nelson | George Kulik | King C. Li | Xiaobo Zhou | Jiguang Bao | G. Kulik | Xiaoqiang Sun
[1] C. I. Bliss. THE TOXICITY OF POISONS APPLIED JOINTLY1 , 1939 .
[2] S. Loewe. The problem of synergism and antagonism of combined drugs. , 1953, Arzneimittel-Forschung.
[3] G. Latta,et al. Ordinary differential equations and their solutions , 1960 .
[4] J. Simard,et al. Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first‐line therapy , 1993, Cancer.
[5] Elizabeth Yang,et al. Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.
[6] B. Kholodenko,et al. Quantification of Short Term Signaling by the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.
[7] S. Srinivasula,et al. Tumor necrosis factor alpha induces BID cleavage and bypasses antiapoptotic signals in prostate cancer LNCaP cells. , 2001, Cancer research.
[8] Xiaodong Wang,et al. Smac is required for cytochrome c-induced apoptosis in prostate cancer LNCaP cells. , 2002, Cancer research.
[9] David Miles,et al. Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] B. Garssen,et al. Psychological factors and cancer development: evidence after 30 years of research. , 2004, Clinical psychology review.
[11] Edna Maria Vissoci Reiche,et al. Stress, depression, the immune system, and cancer. , 2004, The Lancet. Oncology.
[12] Venkat Venkatasubramanian,et al. A hybrid genetic algorithm for efficient parameter estimation of large kinetic models , 2004, Comput. Chem. Eng..
[13] Luc Bijnens,et al. Design and Analysis of Drug Combination Experiments , 2005, Biometrical journal. Biometrische Zeitschrift.
[14] Nils Blüthgen,et al. Mathematical Modeling Identifies Inhibitors of Apoptosis as Mediators of Positive Feedback and Bistability , 2006, PLoS Comput. Biol..
[15] A. Joe,et al. Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapy , 2006, Nature Clinical Practice Oncology.
[16] P. Sorger,et al. Systems biology and combination therapy in the quest for clinical efficacy , 2006, Nature chemical biology.
[17] Sandeep Robert Datta,et al. Diverse Antiapoptotic Signaling Pathways Activated by Vasoactive Intestinal Polypeptide, Epidermal Growth Factor, and Phosphatidylinositol 3-Kinase in Prostate Cancer Cells Converge on BAD* , 2006, Journal of Biological Chemistry.
[18] P. McDonald,et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms , 2006, Nature Reviews Cancer.
[19] George Kulik,et al. Epidermal Growth Factor Protects Prostate Cancer Cells from Apoptosis by Inducing BAD Phosphorylation via Redundant Signaling Pathways* , 2006, Journal of Biological Chemistry.
[20] George Kulik,et al. Epinephrine Protects Cancer Cells from Apoptosis via Activation of cAMP-dependent Protein Kinase and BAD Phosphorylation* , 2007, Journal of Biological Chemistry.
[21] A. Strasser,et al. The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.
[22] J. Tyson,et al. Design principles of biochemical oscillators , 2008, Nature Reviews Molecular Cell Biology.
[23] Jeff Hasty,et al. Delay-induced degrade-and-fire oscillations in small genetic circuits. , 2009, Physical review letters.
[24] Oliver Sawodny,et al. ON/OFF and Beyond - A Boolean Model of Apoptosis , 2009, PLoS Comput. Biol..
[25] Susan E. Abbatiello,et al. Erratum: Synergistic drug combinations tend to improve therapeutically relevant selectivity , 2009, Nature Biotechnology.
[26] R A Knight,et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes , 2009, Cell Death and Differentiation.
[27] Axel Kowald,et al. Systems Biology - a Textbook , 2016 .
[28] Roland Eils,et al. Dynamics within the CD95 death-inducing signaling complex decide life and death of cells , 2010, Molecular systems biology.
[29] Xiaobo Zhou,et al. Cytokine combination therapy prediction for bone remodeling in tissue engineering based on the intracellular signaling pathway. , 2012, Biomaterials.
[30] George Kulik,et al. Targeting psychoemotional stress to treat prostate cancer. , 2013, Asian journal of andrology.
[31] Kyle C. Nelson,et al. BAD Dephosphorylation and Decreased Expression of MCL-1 Induce Rapid Apoptosis in Prostate Cancer Cells , 2013, PloS one.
[32] Sandeep Robert Datta,et al. Behavioral stress accelerates prostate cancer development in mice. , 2013, The Journal of clinical investigation.
[33] Ashok Hemal,et al. A pilot study of blood epinephrine levels and CREB phosphorylation in men undergoing prostate biopsies , 2014, International Urology and Nephrology.
[34] Marie Doumic,et al. Data-Driven Modeling of Src Control on the Mitochondrial Pathway of Apoptosis: Implication for Anticancer Therapy Optimization , 2013, PLoS Comput. Biol..